Gadobutrol Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Gadobutrol Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on Jun 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Package NDC
- 65219-281-15
- Dosage Form
- Injection
- Presentation
- Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15)
- Initial Posting
- Jun 30, 2026